Studies By the National Toxicology Program On Di(2-Ethylhexyl)Phthalate
- 1 April 1987
- journal article
- Published by SAGE Publications in Toxicology and Industrial Health
- Vol. 3 (2) , 99-118
- https://doi.org/10.1177/074823378700300208
Abstract
In a 2-year feed study previously reported by the National Toxicology Program (NTP), the plasticizer di(2-ethylhexyl)phthalate (DEHP) was found to produce increased incidences of hepatocellular neoplasms in both sexes of Fischer 344 (F344) rats and B6C3F1 mice. Further studies by the NTP on this chemical have investigated its genotoxicity, dermal absorption, reproductive and developmental toxicity, and biochemical mechanism of action. DEHP was not mutagenic in Salmonella typhimurium (strains TA98, TA100, TA1535 or TA1537), in L5178Y mouse lymphoma cells, or in Drosophila melanogaster. DEHP did not induce chromosomal aberrations, but did cause a marginal dose-related increase in sister chromatid exchanges in CHO cells. In a dermal absorption study, DEHP was not absorbed well through the skin of F344 rats. In a fertility assessment study, DEHP was shown to be a reproductive toxicant in both male and female CD-1 mice. The teratogenic potential of DEHP was evaluated in F344 rats and CD-1 mice. In the rat study, there were no significant differences in percent fetuses malformed between control and treatment groups, even at dose levels (1.0, 1.5 and 2.0%) which produced significant maternal and fetal toxicity. In the mouse study, the incidence of fetuses with malformations was significantly increased at dose levels which produced maternal and/or fetal toxicity (0.10 and 0.15%), and at a dose level (0.05%) which did not cause maternal or fetal toxicity. The no-observed effect level for developmental toxicity in mice was 0.025% DEHP. Kinetic data on the rates of formation of H2O2 by peroxisomal palmitoyl CoA oxidase, and of degradation of H2O2 by catalase, was used to estimate in vitro steady-state H2O2 concentrations during peroxisofnal oxidation of palmitoyl CoA. Increases in steady-state H 2O2 in liver homogenates of rats treated with DEHP, di(2-ethylhexyl)adipate, or nafenopin, a hypolipidemic drug, correlated well with the carcinogenic potential of these cheniicals determined in previous carcinogenicity studies, and are consistent with but not definitive evidence for the involvement of peroxisome proliferation in the hepatocarcinogenesis of these compounds.Keywords
This publication has 14 references indexed in Scilit:
- Chemical mutagenesis testing in drosophila. IV. Results of 45 coded compounds tested for the national toxicology programEnvironmental Mutagenesis, 1985
- Mutagenicity testing of Di(2‐ethylhexyl)phthalate and related chemicals in SalmonellaEnvironmental Mutagenesis, 1985
- Development of a standard protocol for in vitro cytogenetic testing with Chinese hamster ovary cells: Comparison of results for 22 compounds in two laboratoriesEnvironmental Mutagenesis, 1985
- Enzymatic changes in rat liver associated with low and high doses of a peroxisome proliferatorToxicology and Applied Pharmacology, 1984
- Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to HumansCRC Critical Reviews in Toxicology, 1983
- Lipid-metabolizing enzymes, CoASH and long-chain acyl-CoA in rat liver after treatment with tiadenol, nicotinic acid and niadenateBiochemical Pharmacology, 1982
- The carcinogenicity of dietary di(2‐ethylhexyl) phthalate (DEHP) in fischer 344 rats and B6C3F1miceJournal of Toxicology and Environmental Health, 1982
- INDIVIDUAL PEROXISOMAL βT‐OXIDATION ENZYMES*Annals of the New York Academy of Sciences, 1982
- CatalasePublished by Elsevier ,1974
- Plasticizers from Plastic Devices: Extraction, Metabolism, and Accumulation by Biological SystemsScience, 1970